Fiscal Mismanagement And Infrastructure Deficits Will Lead To Frequent Medicine Shortages In Tunisia
Pharmaceuticals / Tunisia / Thu 16 May, 2024
Key View
- Challenges in Tunisia’s pharmaceutical sector will persist, despite marginal macroeconomic improvements.
- The stability of Tunisia’s pharmaceutical sector will remain reliant on foreign drugmakers, given the underdeveloped domestic pharmaceutical infrastructures.
- Lack of regulatory and pricing transparency will deter new medicine launches